Stewart R B, Grabowski J, Wang N S, Meisch R A
Department of Psychiatry and Behavioral Sciences, Substance Abuse Research Center, University of Texas Health Science Center at Houston 77030-3497, USA.
Psychopharmacology (Berl). 1996 Jan;123(2):111-8. doi: 10.1007/BF02246167.
Methadone usually is taken orally for drug abuse treatment in humans but oral methadone self-administration by laboratory animals has not been investigated extensively. The present study examines acquisition and maintenance of oral methadone maintained responding in four adult male rhesus monkeys. Drug solution was available from one liquid delivery system and water from a second system during daily 3-h sessions. Locations of liquids were reversed each session, and liquid (0.65 ml per delivery) was delivered according to a fixed-ratio reinforcement schedule. Initially a test for the reinforcing effects of 0.00625-0.4 mg/ml methadone solutions was carried out but a consistent preference for drug over water was not seen. To establish methadone as a reinforcer, a fading procedure was used in which responding was first maintained by solutions of methadone (0.00625-0.4 mg/ml) combined with ethanol (0.0325-2.0% w/v). Subsequently, the concentration of the ethanol in the combination was gradually reduced to zero. Methadone-maintained responding (0.4 mg/ml) persisted when ethanol was no longer present. To confirm that the drug was serving as a reinforcer, the dose was varied: (a) by changing the volume delivered while the concentration was held constant and (b) by changing the concentration of the methadone while the volume per delivery was held constant. Over a wide range of doses, deliveries of methadone solution usually exceeded deliveries of concurrently available water. Orderly relationships were observed among methadone dose, response rate, and drug intake. The study of oral self-administration of opioid drugs by nonhuman primates may be a useful strategy for the development and evaluation of new drug substitution or replacement therapies.
美沙酮通常用于人类药物滥用治疗时是口服给药,但实验室动物口服美沙酮的自我给药情况尚未得到广泛研究。本研究考察了四只成年雄性恒河猴口服美沙酮维持反应的习得和维持情况。在每天3小时的实验时段内,一个液体输送系统提供药物溶液,另一个系统提供水。每次实验时段液体的位置会颠倒,并且根据固定比率强化程序输送液体(每次输送0.65毫升)。最初对0.00625 - 0.4毫克/毫升美沙酮溶液的强化效果进行了测试,但未发现对药物的一致偏好超过水。为了将美沙酮确立为强化物,采用了一种递减程序,即反应最初由美沙酮溶液(0.00625 - 0.4毫克/毫升)与乙醇(0.0325 - 2.0% w/v)的混合溶液维持。随后,混合溶液中乙醇的浓度逐渐降至零。当不再有乙醇时,美沙酮维持的反应(0.4毫克/毫升)持续存在。为了确认药物起到了强化物的作用,改变了剂量:(a)在浓度保持恒定的情况下改变输送体积,以及(b)在每次输送体积保持恒定的情况下改变美沙酮的浓度。在很宽的剂量范围内,美沙酮溶液的输送量通常超过同时可获得的水的输送量。在美沙酮剂量、反应率和药物摄入量之间观察到了有序的关系。对非人类灵长类动物口服阿片类药物自我给药的研究可能是开发和评估新的药物替代或替换疗法的有用策略。